Day One Biopharmaceuticals Inc Financial Flexibility Index
Day One Biopharmaceuticals Inc financial flexibility index. Day One Biopharmaceuticals Inc (DAWN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-5.80 Million minus capex $3.82 Million) represents 0% of total liabilities ($62.91 Million). Explore Day One Biopharmaceuticals Inc (DAWN) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Day One Biopharmaceuticals Inc (2019–2024)
Financial flexibility index of Day One Biopharmaceuticals Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Day One Biopharmaceuticals Inc across 6 annual periods. Check DAWN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Day One Biopharmaceuticals Inc Financial Flexibility Index by Year (2019–2024)
Day One Biopharmaceuticals Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Day One Biopharmaceuticals Inc. For the full cash flow conversion analysis, see Day One Biopharmaceuticals Inc (DAWN) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.95x | $-75.94 Million | $-78.11 Million | $80.04 Million | ▲ +80.5% |
| 2023 | -4.87x | $-143.63 Million | $-146.85 Million | $29.51 Million | ▲ +24.6% |
| 2022 | -6.45x | $-109.85 Million | $-109.87 Million | $17.02 Million | ▼ -38.1% |
| 2021 | -4.67x | $-40.54 Million | $-48.54 Million | $8.67 Million | ▲ +23.2% |
| 2020 | -6.09x | $-13.40 Million | $-13.49 Million | $2.20 Million | ▼ -4378.0% |
| 2019 | -0.14x | $-4.42 Million | $-4.51 Million | $32.52 Million | — |